Skip to main content

Amgen guidance

  • AMGN · Nasdaq
  • Biotechnology
  • S&P 500
$465.67−0.30%Close 13 Nov 2026 · Market value $253.3B

In its results release of 3 Nov 2026 (Q3 FY2026), Amgen gave 6 forecasts in figures, among them revenue of $38.90B to $39.70B for FY2026. Over the last two years, results landed above the company's own last range 2 of 8 times, within it 2 and below it 4.

Read from the company's earnings releases and outlook updates of the last two years. Each forecast is shown with the sentence or table row it was read from; what a release does not state in figures is not shown.

Latest guidance given with Q3 FY2026 results, 3 Nov 2026

MeasurePeriodGuidanceAs stated
RevenueFY2026$38.90B to $39.70BTotal revenues in the range of $38.9 billion to $39.7 billion.
EPS · GAAPFY2026$18.34 to $19.28On a GAAP basis, EPS in the range of $18.34 to $19.28, and a tax rate in the range of 14.5% to 16.0%.
EPS · AdjustedFY2026$22.90 to $23.70On a non-GAAP basis, EPS in the range of $22.90 to $23.70, and a tax rate in the range of 15.0% to 16.5%.
Capital expendituresFY2026About $2.60BCapital expenditures to be approximately $2.6 billion.
Tax rate · GAAPFY202614.5% to 16%GAAP tax rate guidance 14.5% - 16.0%
Tax rate · AdjustedFY202615% to 16.5%Non-GAAP tax rate guidance 15.0% - 16.5%

Source: the company's earnings release.

Guidance against results above 2 · within 2 · below 4

The last range given before each period closed, how it moved between releases, and the figure then filed. A measure the company defines itself, or one not comparable with the filed figure, has no verdict.

MeasurePeriodLast guidanceRevisionsDeliveredResult
RevenueFY2026$38.90B to $39.70BRaised twice—To come
EPS · GAAPFY2026$18.34 to $19.28Raised twice—To come
EPS · AdjustedFY2026$22.90 to $23.70Raised twice—To come
Capital expendituresFY2026About $2.60BUnchanged—To come
Tax rate · GAAPFY202614.5% to 16%Unchanged—To come
Tax rate · AdjustedFY202615% to 16.5%Unchanged—To come
RevenueFY2025$35.80B to $36.60BRaised twice$36.75BAbove the range
EPS · GAAPFY2025$13.76 to $14.60Raised once, lowered once$14.23Within the range
Capital expendituresFY2025$2.20B to $2.30BLowered once$1.86BBelow the range
Tax rate · GAAPFY202514.5% to 16%Raised once14.09%Below the range
RevenueFY2024$33.00B to $33.80BGiven once$33.42BWithin the range
EPS · GAAPFY2024$8.71 to $9.56Given once$7.56Below the range
Capital expendituresFY2024About $1.30BGiven once$1.10BBelow the range
Tax rate · GAAPFY20249% to 10.5%Given once11.26%Above the range

AMGN in the terminal

Guidance said on earnings calls, every revision charted, and guidance set against the analysts' consensus.